Mymetics Corp (MYMX) financial statements (2022 and earlier)

Company profile

Business Address EUROPEAN EXECUTIVE OFFICE
EPALINGES, CH-1066
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5711,0836834791,1801,3912,381
Cash and cash equivalents5711,0836834791,1801,3912,381
Receivables157116458590170218
Prepaid expense87858537364166
Total current assets:6731,2399321,1011,3061,6022,665
Noncurrent Assets
Operating lease, right-of-use asset23912827
Property, plant and equipment394852366567106
Intangible assets, net (including goodwill)6,6716,6716,6716,6716,6716,6718,937
Goodwill6,6716,6716,6716,6716,6716,6716,671
Intangible assets, net (excluding goodwill)      2,266
Deposits noncurrent assets1010     
Total noncurrent assets:6,9596,8576,7506,7076,7366,7389,043
TOTAL ASSETS:7,6328,0967,6827,8088,0428,34011,708
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities477016775237120332
Accounts payable477016775237120332
Debt58,47955,68853,378    
Due to related parties8,7907,4025,308    
Other undisclosed current liabilities110105   46,99944,268
Total current liabilities:67,42663,26558,8537523747,11944,600
Noncurrent Liabilities
Long-term debt and lease obligation29218327    
Long-term debt, excluding current maturities162156     
Operating lease, liability1302727
Other undisclosed noncurrent liabilities(130)(27)     
Total noncurrent liabilities:29218327    
Other undisclosed liabilities   54,75850,683  
Total liabilities:67,71863,44858,88054,83350,92047,11944,600
Stockholders' equity
Stockholders' equity attributable to parent(60,086)(55,352)(51,198)(47,025)(42,878)(38,779)(32,892)
Common stock2,5302,5302,5302,5302,5302,5302,530
Additional paid in capital34,44334,44334,44334,44134,42834,39234,315
Accumulated other comprehensive income691695691679667690690
Accumulated deficit(97,750)(93,020)(88,862)(84,675)(80,503)(76,391)(70,427)
Total stockholders' equity:(60,086)(55,352)(51,198)(47,025)(42,878)(38,779)(32,892)
TOTAL LIABILITIES AND EQUITY:7,6328,0967,6827,8088,0428,34011,708

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues4306686539671,5151,2533,154
Revenue, net1,3138741,108
Other income427633542892   
Cost of revenue (42)(110)(24) (2,168) 
Gross profit:4306265439431,515(915)3,154
Operating expenses(2,080)(2,242)(2,034)(2,462)(3,435)(2,492)(3,676)
Other operating expense, net
(Other Expenses)
  (110)    
Other undisclosed operating income3,300 110 408 132
Operating income (loss):1,650(1,616)(1,491)(1,519)(1,512)(3,407)(390)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
329(149)     
Interest and debt expense(2,751)(2,708)(2,674)(2,634)(2,595)(2,571)(2,571)
Other undisclosed income from continuing operations before equity method investments, income taxes5,5028,634     
Income (loss) from continuing operations before equity method investments, income taxes:4,7304,161(4,165)(4,153)(4,107)(5,978)(2,961)
Other undisclosed income (loss) from continuing operations before income taxes(9,460)(8,294)   3 
Loss from continuing operations before income taxes:(4,730)(4,133)(4,165)(4,153)(4,107)(5,975)(2,961)
Income tax expense (benefit) (25)(22)(19)(5)11(45)
Net loss available to common stockholders, diluted:(4,730)(4,158)(4,187)(4,172)(4,112)(5,964)(3,006)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(4,730)(4,158)(4,187)(4,172)(4,112)(5,964)(3,006)
Comprehensive loss:(4,730)(4,158)(4,187)(4,172)(4,112)(5,964)(3,006)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(4)41212(23) 57
Comprehensive loss, net of tax, attributable to parent:(4,734)(4,154)(4,175)(4,160)(4,135)(5,964)(2,949)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: